BLOG

Bispecific antibodies a new hot rod on the anti-cancer circuit

Next-gen bispecific antibodies (BsAbs) are on the move. The blockbuster potential of the class has galvanized biopharma, with deals and assets racing to capture the pole position as the entire field gains speed.

Back to the Blog .st0{stroke:#000;stroke-width:3}.st0,.st1{fill:none}